Operating Lease, Right-of-Use Asset of IGM Biosciences, Inc. from 01 Jan 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IGM Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Jun 2025.
  • IGM Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IGM Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 -$33,040,000 -100% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $28,796,000 -$5,678,000 -16% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $38,524,000 +$2,751,000 +7.7% 31 Dec 2024 10-Q 31 Jul 2025 2025 Q2
Q3 2024 $39,088,000 +$1,995,000 +5.4% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $33,040,000 -$5,373,000 -14% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $34,474,000 -$4,624,000 -12% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $35,773,000 -$3,818,000 -9.6% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $37,093,000 +$10,132,000 +38% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $38,413,000 +$10,339,000 +37% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $39,098,000 +$10,157,000 +35% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $39,591,000 +$11,742,000 +42% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $26,961,000 -$1,603,000 -5.6% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $28,074,000 +$16,151,000 +135% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $28,941,000 +$16,183,000 +127% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $27,849,000 +$16,263,000 +140% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $28,564,000 +$16,332,000 +134% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $11,923,000 -$949,000 -7.4% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $12,758,000 -$750,000 -5.6% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $11,586,000 -$2,551,000 -18% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $12,232,000 +$2,350,000 +24% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $12,872,000 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $13,508,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $14,137,000 +$13,537,000 +2256% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $9,882,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q4 2018 $600,000 01 Jan 2019 10-K 26 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.